Constantinides VC, Paraskevas GP, Paraskevas PG, Stefanis L, Kapaki E. Corticobasal degeneration and corticobasal syndrome: A review. Clin Park Relat Disord. 2019;1:66–71.

PubMed  PubMed Central  Google Scholar 

Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc. 1967;92:23–6.

CAS  PubMed  Google Scholar 

Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968;18(1):20–33.

CAS  PubMed  Google Scholar 

Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain. 1989;112(Pt 5):1171–92.

PubMed  Google Scholar 

Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology. 1999;53(9):1969–74.

CAS  PubMed  Google Scholar 

Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol. 1998;8(2):355–65.

CAS  PubMed  Google Scholar 

Cordato NJ, Halliday GM, McCann H, Davies L, Williamson P, Fulham M, Morris JG. Corticobasal syndrome with tau pathology. Mov Disord. 2001;16(4):656–67.

CAS  PubMed  Google Scholar 

Kaida K, Takeda K, Nagata N, Kamakura K. Alzheimer’s disease with asymmetric parietal lobe atrophy: a case report. J Neurol Sci. 1998;160(1):96–9.

CAS  PubMed  Google Scholar 

Barclay CL, Bergeron C, Lang AE. Arm levitation in progressive supranuclear palsy. Neurology. 1999;52(4):879–82.

CAS  PubMed  Google Scholar 

Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer’s disease. Neurology. 1996;46(3):720–6.

CAS  PubMed  Google Scholar 

Respondek G, Stamelou M, Höglinger GU. Classification of atypical parkinsonism per pathology versus phenotype. Int Rev Neurobiol. 2019;149:37–47.

PubMed  Google Scholar 

Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord. 2014;29(5):684–93.

PubMed  Google Scholar 

Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997;48(4):959–69.

CAS  PubMed  Google Scholar 

Sakae N, Santos OA, Pedraza O, Litvan I, Murray ME, Duara R, et al. Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology. 2020;95(1):e35–45.

CAS  PubMed  PubMed Central  Google Scholar 

de Almeida IJ, Silagi ML, Parmera JB, Brucki SMD, Schochat E. Language in corticobasal syndrome: a systematic review. Dement Neuropsychol. 2021;15(1):16–27.

PubMed  PubMed Central  Google Scholar 

Graham NL, Bak T, Patterson K, Hodges JR. Language function and dysfunction in corticobasal degeneration. Neurology. 2003;61(4):493–9.

PubMed  Google Scholar 

Oliveira LM, Barcellos I, Teive HAG, Munhoz RP. Cognitive dysfunction in corticobasal degeneration. Arq Neuropsiquiatr. 2017;75(8):570–9.

PubMed  Google Scholar 

Luzzi S, Cafazzo V, Silvestrini M, Provinciali L, Pickering-Brown S, Mann D, Snowden JS. Semantic dementia associated with corticobasal syndrome: a further variant of frontotemporal lobe degeneration? J Neurol. 2012;259(7):1478–80.

PubMed  Google Scholar 

Burrell JR, Hornberger M, Villemagne VL, Rowe CC, Hodges JR. Clinical profile of PiB-positive corticobasal syndrome. PLoS ONE. 2013;8(4):e61025.

CAS  PubMed  PubMed Central  Google Scholar 

Di Stefano F, Kas A, Habert MO, Decazes P, Lamari F, Lista S, et al. The phenotypical core of Alzheimer’s disease-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study. Alzheimers Dement. 2016;12(7):786–95.

PubMed  Google Scholar 

Boyd CD, Tierney M, Wassermann EM, Spina S, Oblak AL, Ghetti B, et al. Visuoperception test predicts pathologic diagnosis of Alzheimer disease in corticobasal syndrome. Neurology. 2014;83(6):510–9.

PubMed  PubMed Central  Google Scholar 

Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, et al. Best practices in the clinical management of progressive supranuclear palsy and corticobasal syndrome: a consensus statement of the curepsp centers of care. Front Neurol. 2021;12:694872. Consensus guide developped to help approach the management of CBD and PSP.

Jellinger KA. Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration. J Neural Transm (Vienna). 2023;130(12):1509–22. Review focusing on cognitive and behavioral abnormalities in CBD.

Wilson D, Heron CL, Anderson T. Corticobasal syndrome: a practical guide. Pract Neurol. 2021;21(4):276–85.

Google Scholar 

Alster P, Madetko-Alster N, Migda A, Migda B, Kutyłowski M, Królicki L, Friedman A. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS). Neurol Neurochir Pol. 2023;57(3):229–34. Detailed review on sleep disturbances in CBS and PSPS

Friedman JH, Thomas RJ. Catathrenia in possible progressive supranuclear palsy and corticobasal syndromes. Parkinsonism Relat Disord. 2023;111:105414. Case reports and discussion on catathrenia as a possible occurence in CBS and PSPS

Yousaf T, Pagano G, Wilson H, Politis M. Neuroimaging of sleep disturbances in movement disorders. Front Neurol. 2018;9:767.

PubMed  PubMed Central  Google Scholar 

Ling H, O’Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation Brain. 2010;133(Pt 7):2045–57.

PubMed  Google Scholar 

Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496–503.

PubMed  PubMed Central  Google Scholar 

Shir D, Pham NTT, Botha H, Koga S, Kouri N, Ali F, et al. Clinicoradiologic and neuropathologic evaluation of corticobasal syndrome. Neurology. 2023;101(3):e289–99. Review of clinicoradiologic and neuropathologic findings in a large CBS cohort with pathology-proven diagnosis.

Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, et al. Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome. Brain Commun. 2023;5(6):fcad296. Clinical findings in a CBS cohort with neuropathological correlations

Madetko N, Marzec W, Kowalska A, Przewodowska D, Alster P, Koziorowski D. Anti-IgLON5 disease - the current state of knowledge and further perspectives. Front Immunol. 2022;13:852215. Review summarizing the current state of knowledge on anti-IgLON5 disease.

Hermann P, Zerr I. Rapidly progressive dementias - aetiologies, diagnosis and management. Nat Rev Neurol. 2022;18(6):363–76. Recent review on RPD diverse etiologies, diagnosis process an therapeutic options

Fuseya K, Kimura A, Yoshikura N, Yamada M, Hayashi Y, Shimohata T. Corticobasal syndrome in a patient with anti-IgLON5 antibodies. Mov Disord Clin Pract. 2020;7(5):557–9.

PubMed  PubMed Central  Google Scholar 

Koga S, Roemer SF, Kasanuki K, Dickson DW. Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of “vascular CBS.” Parkinsonism Relat Disord. 2019;68:79–84.

PubMed  PubMed Central  Google Scholar 

Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol. 2011;7(5):263–72.

CAS  PubMed  PubMed Central  Google Scholar 

Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW. Neuropathology and emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatry. 2022;93(9):919–29. Comprehensive review of the neuropathology of CBS.

Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011;70(2):327–40.

PubMed  PubMed Central  Google Scholar 

Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA. 2013;110(23):9535–40.

CAS  PubMed  PubMed Central  Google Scholar 

Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, et al. Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain. 2016;139(Pt 12):3237–52.

PubMed  Google Scholar 

Arima K. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology. 2006;26(5):475–83.

PubMed  Google Scholar 

Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E, et al. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies. Mov Disord. 2020;35(1):171–6.

PubMed  Google Scholar 

Fiock KL, Hook JN, Hefti MM. Determinants of astrocytic pathology in stem cell models of primary tauopathies. Acta Neuropathol Commun. 2023;11(1):161. Study focusing on determining the origins of astrocytic tau in 4R tauopathies.

Kovacs GG. Astroglia and Tau: New Perspectives. Front Aging Neurosci. 2020;12:96.

CAS  PubMed  PubMed Central  Google Scholar 

Uchihara T. Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology. 2014;34(6):571–7.

CAS  PubMed  Google Scholar 

Gelpi E, Höftberger R, Graus F, Ling H, Holton JL, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132(4):531–43.

CAS  PubMed  PubMed Central  Google Scholar 

Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH, et al. Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e136.

PubMed